SCHEMBL8367726

SCHEMBL8367726

O=C(NCc1ccncc1)c1ccc(NS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.78
▸ NAMPT P43490 5/20 0.69
▸ MMP13 P45452 2/20 0.64
▸ ALDH1A1 P00352 2/20 0.62
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ USP2 O75604 1/20 0.62
▸ PKM P14618 1/20 0.62
▸ CA2 P00918 1/20 0.61
▸ NPC1 O15118 1/20 0.60
▸ ROCK2 O75116 1/20 0.60
▸ RPS6KA5 O75582 1/20 0.60
▸ MAP4K4 O95819 1/20 0.60
▸ PRKCG P05129 1/20 0.60
▸ PRKACA P17612 1/20 0.60
▸ RPS6KB1 P23443 1/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ AKT1 P31749 1/20 0.60
▸ GSK3A P49840 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12010899 0.85 MAPT (0.72) TDP1NAMPTALDH1A1KMT2AMEN1
SCHEMBL20379238 0.85 NAMPT (0.93) NAMPTHTT
SCHEMBL19358884 0.82 CXCR4 (0.73) NAMPTMMP13ALDH1A1SMN1; SMN2CA2
SCHEMBL12010903 0.82 TDP1 (0.91) TDP1NAMPTALDH1A1KMT2AMEN1
SCHEMBL20379606 0.81 NAMPT (1.00) NAMPTHTT
SCHEMBL1161697 0.81 MMP13 (0.82) NAMPTMMP13ALDH1A1SMN1; SMN2CA2
SCHEMBL12010898 0.81 MAPT (0.80) TDP1NAMPTALDH1A1KMT2AMEN1
SCHEMBL5493611 0.79 MEN1 (0.64) TDP1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL5310949 0.78 HDAC1 (0.62) TDP1NAMPTALDH1A1KMT2AMEN1
SCHEMBL539269 0.78 MMP13 (1.00) NAMPTMMP13SMN1; SMN2CA2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831800-A4 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS DIMENSIONAL PHARM INC (US) 1999-03-10 — — EP disclosed
US-5741819-A THROMBOSIS INHIBITORS; ANTIINFLAMMATORY AGENTS; NEURODEGENERATIVE DISORDERS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-04-21 — — US disclosed
EP-0831800-A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-04-01 — — EP disclosed
WO-1996040100-A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1996-12-19 — — WO disclosed
Send feedback